Details for New Drug Application (NDA): 212628
✉ Email this page to a colleague
The generic ingredient in TOBRAMYCIN is tobramycin sulfate. There are eighteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the tobramycin sulfate profile page.
Summary for 212628
Tradename: | TOBRAMYCIN |
Applicant: | Gland Pharma Ltd |
Ingredient: | tobramycin |
Patents: | 0 |
Suppliers and Packaging for NDA: 212628
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TOBRAMYCIN | tobramycin | SOLUTION/DROPS;OPHTHALMIC | 212628 | ANDA | Belcher Pharmaceuticals, LLC | 62250-110 | 62250-110-01 | 1 BOTTLE, PLASTIC in 1 CARTON (62250-110-01) / 5 mL in 1 BOTTLE, PLASTIC |
TOBRAMYCIN | tobramycin | SOLUTION/DROPS;OPHTHALMIC | 212628 | ANDA | Gland Pharma Limited | 68083-374 | 68083-374-01 | 1 BOTTLE, PLASTIC in 1 CARTON (68083-374-01) / 5 mL in 1 BOTTLE, PLASTIC |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.3% | ||||
Approval Date: | Mar 9, 2021 | TE: | AT | RLD: | No |
Complete Access Available with Subscription